NEOGEN — Neogen Chemicals Income Statement
0.000.00%
- IN₹41.66bn
- IN₹45.90bn
- IN₹6.91bn
Annual income statement for Neogen Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,061 | 3,364 | 4,873 | 6,862 | 6,907 |
Cost of Revenue | |||||
Gross Profit | 902 | 999 | 1,445 | 1,995 | 2,390 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,533 | 2,790 | 4,124 | 5,908 | 6,035 |
Operating Profit | 528 | 575 | 749 | 954 | 872 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 411 | 442 | 571 | 710 | 528 |
Provision for Income Taxes | |||||
Net Income After Taxes | 287 | 313 | 446 | 500 | 357 |
Net Income Before Extraordinary Items | |||||
Net Income | 287 | 313 | 446 | 500 | 357 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 287 | 313 | 446 | 500 | 357 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 12.3 | 13.4 | 17.9 | 20 | 14 |
Dividends per Share |